TBA Law Blog


Posted by: Stacey Shrader Joslin on Sep 11, 2023

The Biden administration formally asked the U.S. Supreme Court on Friday to overturn a ruling from a federal appeals court that would limit the availability of the abortion pill mifepristone, The Hill reports. The manufacturer of the brand name pill, Danco Laboratories, also filed an appeal with the court. In August, the U.S. Court of Appeals for the Fifth Circuit ruled that the drug could stay on the market in states where abortion is legal, but struck down changes made in 2016 to expand access. The appeals court said those changes did not follow proper procedure. Its decision, however, remains on hold while the Supreme Court decides whether to take up the case.